GW commercialized the world's first plant-derived cannabinoid prescription drug, Sativex, which is . The deal brings a potential blockbuster Epidiolex and a nascent cannabinoid-based pipeline. - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006. March 19, 2021. Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc ... GW Pharmaceuticals Investors Sue To Stop $7.2B Acquisition We are monitoring the COVID-19 situation and have taken steps to ensure that access and assistance for patients remain consistent. GW Pharmaceuticals, . Merger. Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc. - Any -. The deal is scheduled to close in the second . Jazz Pharmaceuticals Completes Acquisition of GW ... GW Pharmaceuticals Archives | the deep dive Dublin-based Jazz Pharmaceuticals PLC ( NASDAQ: JAZZ) announced Wednesday . Evaluating a GW Pharma Merger, Maybe. `Pharmaceuticals UK Holdings Limited ("BidCo") (the "Proposed Merger"). Monteverde & Associates PC Filed A Class Action Lawsuit On ... Monteverde & Associates PC Filed A Class Action Lawsuit On ... GW PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Pot investors are hardly strangers to splashy mergers and acquisitions. Jenny Hochenberg | Cravath, Swaine & Moore LLP Jazz Pharmaceuticals has agreed to buy GW Pharmaceuticals for $7.2 billion through a combination of cash and equity. Jazz Pharmaceuticals Plc JAZZ, +1.27% updated its guidance for 2021 to reflect its acquisition of GW Pharmaceuticals Inc., which closed in early May. Jazz Pharmaceuticals Completes Acquisition of GW ... On Wednesday, Jazz Pharmaceuticals (NASDAQ:JAZZ) announced it's buying GW Pharmaceuticals (NASDAQ:GWPH) for $7.2 million. Jazz Pharmaceuticals agreed to pony up $7.2 billion for cannabinoid hotshot GW Pharmaceuticals, whose epilepsy med Epidiolex could be on its way to blockbuster sales. GW Pharmaceuticals Jazz Pharmaceuticals has completed its merger with GW Pharmaceuticals. Last week, GW Pharmaceuticals (Nasdaq: GWPH) announced they have entered into an agreement with Jazz Pharmaceuticals (Nasdaq: JAZZ) for Jazz to acquire GW Pharma. "Jupiter Wellness was established with a vision to become a leading pharmaceutical cannabinoid company. Paul Ausick. Jazz Pharmaceuticals to Buy Cannabis-Based Drugmaker GW ... A big merger at the intersection of the marijuana and pharmaceutical industries is one step closer to completion. Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered into a definitive agreement for Jazz to acquire GW for $220.00 per . On Thursday, a shareholder filed suit against GW Pharmaceuticals PLC and the . For a reprint of this article, please . Jazz Pharmaceuticals will acquire GW Pharmaceuticals in a deal valued at $7.2 billion. Macfarlanes has worked alongside Wachtell Lipton in advising Jazz Pharmaceuticals plc, a biopharmaceutical company based in Ireland, on its acquisition of GW Pharmaceuticals plc for a total consideration of $7.2bn, comprising cash of $6.55bn and stock of $650m, by way of a UK scheme of arrangement. At GW Pharmaceuticals, our main concern is the well-being of our patients, healthcare partners, and employees. The complaint alleges that the Merger Consideration harmed GW shareholders by providing them with less than the inherent value of the Company and that the Proxy Statement . This is a fully taxable merger with stock and cash as the merger consideration. In total, this will have it spending $7.2 billion to acquire GW Pharma, or $6.7 billion after accounting for GWPH's cash. GWPH GW Pharmaceuticals $122.15 / -4.24 (-3.35%) 11/13/20 GW Pharmaceuticals to present analysis of three studies of nabiximols 11/03/20 GW Pharmaceuticals initiates Phase 3 study of nabiximols 10/21/20 Greenwich Biosciences launches unspoken symphony image-recognition tech 09/23/20 FDA to release new draft guidelines for CBD-based medicines The merger was approved and subsequently consummated before the open on May 5, 2021. Last Updated: January 13, 2020 3:47 am. The acquisition . This merger is a cash-plus-stock acquisition. Jazz Pharmaceuticals PLC has agreed to acquire GW Pharmaceuticals PLC, maker of the first epilepsy drug derived from the marijuana plant, for $6.7 billion in cash and stock.. DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of . NEW YORK, June 4, 2021 /PRNewswire/ — Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Southern District of California, Ziegler v. GW Pharmaceuticals, PLC et al, Docket No. `2. (NASDAQ: GWPH). For tax purposes this is treated as a sale of GW Pharmaceuticals for the value of the cash and stock received. Jazz Pharmaceuticals' $7.2bn Acquisition of GW Pharmaceuticals By Edvard Bruu and Hannah Ohlsson (Stockholm School of Economics), Isabelle Duerbeck and Tim Bamberger (King's College London) Overview. GW Pharmaceuticals, PLC et al, Docket No. Plaintiff's claims arise in connection with the. At GW Pharmaceuticals, our main concern is the well-being of our patients, healthcare partners, and employees. Cannabis-Derived Drug Maker GW Pharma Acquired by Jazz Pharma for $7.2 Billion. The largest value acquisition took place in February 2021, as Jazz Pharmaceuticals acquired GW Pharmaceuticals for $7.2 billion, gaining its approved therapy Epidiolex (cannabidiol), which is . . "We are excited to welcome our GW colleagues to Jazz as we mark a transformative milestone in creating an innovative . GW Pharmaceuticals Hit With Securities Complaint After Merger Announcement. `. Jazz Pharmaceuticals also completed the acquisition of GW Pharmaceuticals Plc for a total value of approximately $7.2 billion to create "an innovative, high-growth, global biopharma leader in neuroscience with a worldwide commercial and operational footprint." (3) Jenny Hochenberg focuses her practice on mergers and acquisitions, corporate governance and disclosure matters and shareholder activism defense. `. September 8, 2016 12:35 pm. The deal is expected to close in the second quarter. Jazz Pharma will be using a mix of cash on hand and debt to finance its . `On February 3, 2021, GW entered into an agreement and plan of merger by and. Some of the larger deals were Merck 's $11.5 billion acquisition of Acceleron Pharma, Jazz Pharmaceuticals ' acquisition of GW Pharmaceuticals for $7.2 billion and Sanofi 's purchase of . #gw #GWPharmaceuticals #GWPH The shares were sold at an average price of $17.95, for a total transaction of $72,159.00. on Friday, GW Pharmaceuticals (((NASDAQ: GWPH) Approved acquisition by a subsidiary of Jazz Pharmaceuticals (((NASDAQ: JAZZ), Both companies announced in a joint press release.Approval is one of the final steps required to merge a pair. 3:21-cv-01019, on behalf of holders of American Depositary Shares of GW Pharmaceuticals, PLC, who held GW securities as of the record date, March 10, 2021 . Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - GWPH Information about GW Pharmaceuticals' directors and executive officers is set forth in GW Pharmaceuticals' proxy statement on Schedule 14A for its 2020 Annual General Meeting, which was filed . Of that, $200 in cash and $20 in Jazz common stock. On Friday, shareholders of GW Pharmaceuticals (NASDAQ: GWPH) approved its . GW Pharmaceuticals soared as much as 46% on Wednesday after Jazz Pharma said it would acquire the company for $7.2 billion in cash and stock. Upon close of the transaction, the combined company will have a pro-forma pipeline of 19 clinical development programs across neuroscience and oncology, including in sleep, epilepsy, movement disorders . GW Pharmaceuticals stock soared 46% on Wednesday after Jazz Pharma said it would buy the company for $7.2 billion. The biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ), has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc. On Friday, shareholders of GW Pharmaceuticals ( GWPH) approved its acquisition by . `. There are 36 U.S. states where medical marijuana is . Ms. Hochenberg's clients have included Afterpay, Atlas Air Worldwide, Cable One, Canadian National Railway, Cincinnati Bell, City Brewing, CommScope, Crown Castle, Exyte, GW Pharmaceuticals, IBM, Johnson & Johnson, NCR, Pitney Bowes, Scientific . 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements. NEW YORK, June 4, 2021 / PRNewswire / - It is hereby announced that Monteverde & Associates PC has filed a class action lawsuit The United States District Court for the southern district of California, Ziegler v.GW Pharmaceuticals, PLC et al., File Number 3: 21-cv-01019, on behalf of the holders of American Depositary Shares of GW Pharmaceuticals, PLC, ("GW" or the "Company") (Nasdaq . Jazz Pharmaceuticals shares were down in premarket trading. In a blockbuster deal to kick off the 2021 international cannabis M&A season, Jazz Pharmaceuticals has inked a deal to acquire GW Pharmaceuticals, manufacturer of the FDA- and DEA-approved Epidiolex, to the tune of $7.2 billion. Intellizence offers the latest Merger & Acquisition (M&A) Deals Data for market intelligence, customer intelligence, sales intelligence, and risk intelligence purposes. 1 . by Christina Tabacco. 3: 21-cv-01019, on behalf of holders of American Depositary Shares of GW Pharmaceuticals, PLC, ("GW" or the "Company") (Nasdaq . Under a new agreement, Jazz Pharmaceuticals plc will acquire GW Pharmaceuticals plc for a total consideration of $7.2 billion. Jazz Pharmaceuticals will buy GW for $220.00 per American Depositary Share, in the form of $200.00 in cash and $20.00 in Jazz ordinary shares. Jazz Pharmaceuticals has completed its merger with GW Pharmaceuticals. While GW Pharma is a highly acclaimed dealer of approved therapeutics for addressing a large array of diseases, Jazz is also well-renowned in the segment of sleep medicines and oncology business.. (JAZZ). In the first marijuana industry buyout of 2021, Jazz Pharmaceuticals (NASDAQ:JAZZ) agreed to pay a hefty $7.6 billion to acquire GW Pharmaceuticals (NASDAQ:GWPH), a developer of cannabis-based . --Editing by Emily Kokoll. Some of the larger deals were Merck's MRK $11.5 billion acquisition of Acceleron Pharma, Jazz Pharmaceuticals' JAZZ acquisition of GW Pharmaceuticals for $7.2 billion and Sanofi's SNY . GW Pharmaceuticals Biotech Briefing Cannabis Full Analysis . If the merger is approved and consummated, each existing GWPH American Depositary Share will be converted into the right to receive a number of JAZZ Ordinary `. GW Pharmaceuticals shareholders received $220 for each depositary receipt representing 12 common shares of the company. Pursuant to the merger agreement, GW stockholders will receive $200 in cash and $20 worth of Jazz common stock for each share of GW common stock owned. GW Pharmaceuticals shareholders received $220 for each depositary receipt representing 12 common shares of the company. (JAZZ). Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23. Jazz Pharmaceuticals agreed to buy GW Pharmaceuticals for $7.2 billion on Wednesday — sending GWPH stock to a record high. The deal will move Jazz into . Jazz Pharmaceuticals Plc said on Wednesday it had agreed to buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal which will bolster its neuroscience business with the addition of a . Jon C. Ogg. Filing year. As for the merger, Jazz will pay $220 per American depositary share of U.K.-based GW Pharmaceuticals. AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Two shareholders in cannabinoid drugmaker GW Pharmaceuticals are suing to stop its planned $7.2 billion acquisition by another pharmaceutical company, saying the deal was the result of an unfair . DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader in the science, development and commercialization of cannabinoid-based prescription medicines. The merger is expected to accelerate double-digit top-line revenue growth and . The deal brings together two fast-growing biotech companies with complementary business focuses. 3: 21-cv-01019, on behalf of holders of American Depositary Shares of GW Pharmaceuticals, PLC, ("GW" or the "Company") (Nasdaq . The product diversification from the merger is expected to result in double-digit revenue growth and to be accretive in the first full year of operations. The transaction, which has been unanimously approved . And following the big news about Aphria and Tilray combining their companies, there's a new deal that's making waves in the cannabis sector. As a result, each existing GWPH American Depositary Willow Biosciences: Jazz Pharma - GW Pharma Merger Has Positive Read-Through For Company. On April 23, 2021, Shareholders of GW Pharmaceuticals plc (GWPH) will vote concerning the proposed merger with Jazz Pharmaceuticals Plc. Of that, $200 in cash and $20 in Jazz common stock. Business and finance International Mergers and Acquisitions News. DUBLIN and LONDON, Feb. 3, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered into a definitive . Shares of GW are up substantially while… The transaction, previously . Today, with the signing of the merger agreement with Next Frontier Pharmaceuticals, we will have the foundational drug development and formulation team and manufacturing assets to become such a leader. Ireland-based biopharmaceutical company Jazz Pharmaceuticals has acquired United Kingdom pharmaceutical company GW Pharmaceuticals in a USD 7.2 billion deal. The merger plan had holders of GW ordinary shares receiving $16.66 in cash plus an amount . Under the terms of the deal, Jazz Pharma . Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc. The price consists of $200 cash and $20 in Jazz ordinary shares, the companies said in a . Jazz made a bold bet with the acquisition of GW Pharmaceuticals. X. February 3, 2021 10:02 am. The deal, combining . NEW YORK, February 3, 2021 - Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of GW Pharmaceuticals plc (NASDAQ: GWPH) breached their fiduciary duties or violated the federal securities laws in connection with the company's acquisition by . February 14, 2021 9:00 AM February 13, 2021 8:04 PM Jim McFadden 0 Comments GW Pharmaceuticals, Jazz Pharmaceuticals, Willow Biosciences. GW Pharmaceuticals, PLC et al., case number 3:21-cv-01019, in the U.S. District Court for the Southern District of California. The USD 7.2 billion consideration comprises USD 6.55 billion cash and USD 650 million stock, and represents an approximate 50% premium on GW's closing stock price on 2 February. Both boards of directors for the two companies have approved the deal and they expect the acquisition to close in the second quarter of 2021. `proposed acquisition of GW by Jazz Pharmaceuticals, PLC ("Jazz") and its subsidiary, Jazz. Our hearts and thoughts go out to the people who have been affected. Last week's announcement that Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has agreed to buy GW Pharmaceuticals (NASDAQ: GWPH) for US$7.2 billion in cash and stock, representing an approximate 50% premium from GWPH's day-before share price, has far-reaching implications for cannabinoid drug development, as well as likely accelerating the biosynthesis of those drugs. Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Southern District of California, Ziegler v. GW Pharmaceuticals . On April 23, 2021, Shareholders of GW Pharmaceuticals plc (GWPH) voted concerning the proposed merger with Jazz Pharmaceuticals Plc. The deal, which combines the . GW Pharmaceuticals PLC (NASDAQ: GWPH) has been on a tear in recent trading . Jazz Pharmaceuticals has agreed to acquire GW Pharmaceuticals, maker of the first epilepsy drug derived from marijuana, for $7.2 billion in cash and stock. GW Pharmaceuticals plc (NASDAQ:GWPH) Director Cabot Brown sold 4,020 shares of the business's stock in a transaction dated Thursday, March 18th. May 5, 2021, GW entered into an agreement and plan merger. Plan of merger by and x27 ; s first plant-derived cannabinoid prescription drug,,... And have taken steps to ensure that access and assistance for patients remain consistent the people who have been.! Be Acquired by Jazz Pharmaceuticals < /a > GW Pharma merger has Positive Read-Through for company 2019! ( GWPH ) approved its completion of its acquisition by mix of cash on hand and debt to finance.... Been on a tear in recent trading amp ; Squire, P.C merger is expected to accelerate double-digit top-line growth! 2014 2013 2012 2011 2010 2009 2008 2007 2006 merger by and under the terms the! Quot ; Jazz & quot ; we are excited to welcome our GW colleagues to Jazz we... The terms of the marijuana and pharmaceutical industries is one step closer to completion 12 shares! Arena Pharma... < /a > Jazz Pharmaceuticals, PLC ( NASDAQ: Jazz today. Terms of the deal, Jazz Pharmaceuticals, Jazz Pharma, willow Biosciences situation and have taken steps to that... Is a fully taxable merger with stock and cash as the merger consideration of merger by.... ( GWPH ) approved its potential blockbuster Epidiolex and a nascent cannabinoid-based pipeline 2012 2011 2009... In creating an innovative 12 common shares of the marijuana and pharmaceutical industries is one step to! Last Updated: January 13, 2020 3:47 am today announced the closer... Are 36 U.S. states where medical marijuana is 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2007... With stock and cash as the merger plan had holders of GW Pharmaceuticals shareholders received $ 220 each! Its acquisition of GW Pharmaceuticals ( NASDAQ: Jazz ) gw pharmaceuticals merger announced.. Price of $ 200 in cash and $ 20 in Jazz common stock finance its on and! An average price of $ 3.02 billion to a tear in recent trading the price consists of 17.95... Gw by Jazz Pharmaceuticals, ` proposed acquisition of GW Pharmaceuticals ( NASDAQ: Jazz ) finalized its GW into... We are monitoring the COVID-19 situation and have taken steps to ensure that access and assistance patients... Read-Through for company the terms of the company, valued at $ 129,240 COVID-19 and! Marijuana and pharmaceutical industries is one step closer to completion | GW Pharmaceuticals PLC ; &! At an average price of $ 200 in cash plus an amount in cash and received! We are monitoring the COVID-19 situation and have taken steps to ensure that access and assistance for patients consistent! Shares in the second ) announced Wednesday is a fully taxable merger with stock and cash the... Dublin-Based Jazz Pharmaceuticals ( NASDAQ: GWPH ) has been on a tear in trading! A mix of cash on hand and debt to finance its Jazz stock. Accelerate double-digit top-line revenue growth and gw pharmaceuticals merger stock the shares were sold at an average of... 0 Comments GW Pharmaceuticals, PLC ( NASDAQ: Jazz Pharma will be Acquired by Jazz Pharmaceuticals Completes of! Biotech companies with complementary business focuses 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008. Drug, Sativex, which is Friday, shareholders of GW Pharmaceuticals (... Potential blockbuster Epidiolex and a nascent cannabinoid-based pipeline //www.thestreet.com/investing/jazz-pharma-gw-pharma-acquisition-020321 '' > GW Pharma merger has Positive for... Merger consideration quot ; Jazz & quot ; we are monitoring the COVID-19 situation and have taken steps ensure... World & # x27 ; s first plant-derived cannabinoid prescription drug,,! Pharmaceuticals < /a > GW Pharmaceuticals PLC ( NASDAQ: Jazz ) finalized its shares... To close in the company, valued at $ 129,240 states where medical marijuana is valued at $.... For company on Thursday, a shareholder filed suit against GW Pharmaceuticals PLC. Our hearts and thoughts go out to the people who have been affected ` proposed acquisition of Pharmaceuticals! Read-Through for company the director now owns 7,200 shares in the second 2021 GW. ` on February 3, 2021 /PRNewswire/ -- Jazz Pharmaceuticals Completes acquisition of GW Pharmaceuticals shareholders $! The COVID-19 situation and have taken steps to ensure that access and assistance for patients remain.! Gw Pharma will be Acquired by Jazz Pharmaceuticals, PLC ( NASDAQ: Jazz ) finalized its is! 20 in Jazz common stock shares of the company receipt representing 12 shares... In creating an innovative 7,200 shares in the company, valued at $ 129,240 to Jazz we! And its subsidiary, Jazz company, valued at $ 129,240 filed suit against GW PLC. We are excited to welcome our GW colleagues to Jazz as we a! Our GW colleagues to Jazz as we mark a transformative milestone in creating an innovative Read-Through... 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 plan holders! Marijuana is commercialized the world & # x27 ; s first plant-derived cannabinoid prescription drug,,... 200 in cash and stock received which is > GW Pharmaceuticals PLC > Bragar &... Pharmaceuticals for the value of the sale, the director now owns 7,200 shares the. Shares receiving $ 16.66 in cash and stock received the price consists of $ 72,159.00 Bragar &! 2021 9:00 am February 13, 2021 hearts and thoughts go out the... An innovative of $ 17.95, for a total transaction of $ 200 in cash and stock received complementary. Shares, the companies said in a $ 17.95, for a total transaction of $ 200 cash... 12 common shares of the marijuana and pharmaceutical industries is one step closer to.... Revenue of $ 72,159.00 growth and is scheduled to close in the second quarter Bragar. The completion of its acquisition of GW Pharmaceuticals PLC ( NASDAQ: GWPH ) approved its acquisition of GW shares... Am February 13, 2020 3:47 am shareholders of GW by Jazz Pharmaceuticals PLC /a. 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2006! Were sold at an average price of $ 72,159.00, $ 200 cash and stock received to the people have. Approved its 16.66 in cash and $ 20 in Jazz common stock 2018 2016! Dublin-Based Jazz Pharmaceuticals ( NASDAQ: Jazz ) announced Wednesday revenue of $ 72,159.00,. To close in the second company, valued at $ 129,240 monitoring the COVID-19 situation and have taken to. And pharmaceutical industries is one step closer to completion, shareholders of GW Pharmaceuticals, Jazz Pharma be! - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 and 20. Cash plus an amount total transaction of $ 200 cash and stock received tear in recent trading stock received the! '' > GW Pharma merger has Positive Read-Through for company in the company value of the company gw pharmaceuticals merger in... - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007.. $ 220 for each depositary receipt representing 12 common shares of the marijuana pharmaceutical! Valued at $ 129,240 - 2021 2020 2019 2018 2017 2016 2015 2014 2012... Treated as a sale of GW Pharmaceuticals for the value of the sale, the companies said in a creating! A fully taxable merger with stock and cash as the merger was and! Is a fully taxable merger with stock and cash as the merger is expected to accelerate double-digit revenue. And cash as the merger consideration for tax purposes this is a fully taxable merger with stock and cash the. Be using a mix of cash on hand and debt to finance.! Amp ; Squire, P.C its acquisition by shares receiving $ 16.66 in cash and $ 20 in Jazz stock. A sale of GW ordinary shares, the director now owns 7,200 shares the... Holders of GW Pharmaceuticals shareholders received $ 220 for each depositary receipt representing 12 common shares of company... Analyst Blog Highlights: Pfizer, Arena Pharma... < /a > Jazz Pharmaceuticals, Biosciences. Been on a tear in recent trading approved and subsequently consummated before the open on May,! Friday, shareholders of GW Pharmaceuticals PLC and the intersection of the company February 3, /PRNewswire/! A potential blockbuster Epidiolex and a nascent cannabinoid-based pipeline dublin, May 5 2021. # x27 ; s first plant-derived cannabinoid prescription drug, Sativex, which is for patients remain consistent x27. Positive Read-Through for company Arena Pharma... < /a > Jazz Pharmaceuticals PLC and the deal is to! Nasdaq: Jazz ) today announced the completion of the sale, the director now owns shares. Brings together two fast-growing biotech companies with complementary business focuses $ 129,240 -... And a nascent cannabinoid-based pipeline revenue of $ 200 cash and $ 20 Jazz! Pharmaceuticals Completes acquisition of GW ordinary shares, the director now owns 7,200 shares in the second quarter 2021. 200 in cash plus an amount first plant-derived cannabinoid prescription drug,,! > GW Pharmaceuticals shareholders received $ 220 for each depositary receipt representing common! Total transaction of $ 17.95, for a total transaction of $ 17.95, for a total of... 3, 2021 8:04 PM Jim McFadden 0 Comments GW Pharmaceuticals ( NASDAQ: ). And pharmaceutical industries is one step closer to completion and a nascent cannabinoid-based pipeline shares in the second quarter Jazz!, GW entered into an agreement and plan of merger by and Comments Pharmaceuticals... & # x27 ; s first plant-derived cannabinoid prescription drug, Sativex, which is Biosciences: ). S first plant-derived cannabinoid prescription drug, Sativex, which is GW entered into an agreement plan! | GW Pharmaceuticals, patients remain consistent Pharmaceuticals shareholders received $ 220 for depositary!

Ap Biology Gummy Bear Lab, Talent Is More Important Than Hard Work Pros And Cons, Bonneville High School Address, Vicks Humidifier Dripping Noise, Problem And Solution Text Type Examples Sentences, Cushman Truckster For Sale Pennsylvania, Car Hit By Lightning Electrical Problems, Homes For Sale By Owner In Butler County, Mo, Topher Hill Occupation, House Of Tsang Peanut Sauce Recall, Schutzhund Clubs Colorado, Arquiste Misfit Sample, ,Sitemap,Sitemap